Skip to main content
NCBI home page
Gut logoLink to Gut
. 1978 Dec;19(12):1105–1109. doi: 10.1136/gut.19.12.1105

Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.

S P Kane, I M Murray-Lyon, F J Paradinas, P J Johnson, R Williams, A H Orr, J Kohn
PMCID: PMC1412330  PMID: 84776

Abstract

Grossly raised levels of tumour related vitamin B12 binding protein, reflected by rises in serum vitamin B12 and unsaturated vitamin B12 binding capacity (UBBC), were found in three of 44 patients with hepatocellular carcinoma. All three were HBsAg negative and had normal serum alpha fetoprotein levels. The patients did not have underlying cirrhosis and the tumours contained characteristic intracellular inclusions. In the first patient the UBBC level fell during a partial remission induced by adriamycin therapy and in the second patient UBBC levels rose with progression of her disease. In the third patient serum B12 binding protein levels fell after tumour resection. Assay and subsequent monitoring of serum vitamin B12 and UBCC may prove valuable in the assessment and follow-up of some patients with hepatocellular carcinoma whose alpha fetoprotein levels are normal.

Full text

PDF
1105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONOVITCH J., GROSSOWICZ N., RACHMILEWITZ M. Serum concentrations of vitamin B12 in acute and chronic liver disease. J Lab Clin Med. 1956 Sep;48(3):339–344. [PubMed] [Google Scholar]
  2. Alpert E. Human alpha1-fetoprotein (AFP): developmental biology and clinical significance. Prog Liver Dis. 1976;5:337–349. [PubMed] [Google Scholar]
  3. Burger R. L., Waxman S., Gilbert H. S., Mehlman C. S., Allen R. H. Isolation and characterization of a novel vitamin B12-binding protein associated with hepatocellular carcinoma. J Clin Invest. 1975 Nov;56(5):1262–1270. doi: 10.1172/JCI108202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carmel R., Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer. 1977 Sep;40(3):1348–1353. doi: 10.1002/1097-0142(197709)40:3<1348::aid-cncr2820400352>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Carmel R. Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med. 1975 Feb 6;292(6):282–284. doi: 10.1056/NEJM197502062920603. [DOI] [PubMed] [Google Scholar]
  6. Carmel R. Vitamin B 12-binding protein abnormality in subjects without myeloproliferative disease. I. Elevated serum vitamin B 12-binding capacity levels in patients with leucocytosis. Br J Haematol. 1972 Jan;22(1):43–51. doi: 10.1111/j.1365-2141.1972.tb08785.x. [DOI] [PubMed] [Google Scholar]
  7. Chu M. L., Lin W. S., Yoshida T. O., Chu S. H., Lin T. Y. Demonstration of alpha-Fetoglobulin in hepatoma tissue by fluorescent antibody technique. Cancer. 1974 Aug;34(2):268–273. doi: 10.1002/1097-0142(197408)34:2<268::aid-cncr2820340208>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  8. Cohen C. Intracytoplasmic hyaline globules in hepatocellular carconomas. Cancer. 1976 Apr;37(4):1754–1758. doi: 10.1002/1097-0142(197604)37:4<1754::aid-cncr2820370421>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  9. GOTTLIEBLAU K. S., WASSERMAN L. R., HERBERT V. RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITY. Blood. 1965 Jun;25:875–884. [PubMed] [Google Scholar]
  10. Herbert V. Diagnostic and prognostic values of measurement of serum vitamin B12-binding proteins. Blood. 1968 Aug;32(2):305–312. [PubMed] [Google Scholar]
  11. Johnson P. J., Williams R., Thomas H., Sherlock S., Murray-Lyon I. M. Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet. 1978 May 13;1(8072):1006–1009. doi: 10.1016/s0140-6736(78)90735-3. [DOI] [PubMed] [Google Scholar]
  12. Kane S. P., Hoffbrand A. V., Neale G. Indices of granulocyte activity in inflammatory bowel disease. Gut. 1974 Dec;15(12):953–959. doi: 10.1136/gut.15.12.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murray-Lyon I. M., Williams R. Quantitative immunoelectrophoresis of plasma proteins in acute viral hepatitis, extrahepatic biliary obstruction, primary biliary cirrhosis and idiopathic haemochromatosis. Clin Chim Acta. 1974 Mar 26;51(3):303–308. doi: 10.1016/0009-8981(74)90316-7. [DOI] [PubMed] [Google Scholar]
  14. Nexo E., Olesen H., Norredam K., Schwartz M. A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma. Scand J Haematol. 1975 Jun;14(5):320–327. doi: 10.1111/j.1600-0609.1975.tb02703.x. [DOI] [PubMed] [Google Scholar]
  15. Nexö E., Olesen H., Christensen J. M., Thomsen J., Kristiansen K. Characterization of a cobalamin-binding plasma protein from a patient with hepatoma. Scand J Clin Lab Invest. 1975 Nov;35(7):683–690. doi: 10.1080/00365517509095798. [DOI] [PubMed] [Google Scholar]
  16. Palmer P. E., Wolfe H. J. Alpha-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med. 1976 May;100(5):232–236. [PubMed] [Google Scholar]
  17. Waxman S., Gilbert H. S. A tumor-related vitamin B12 binding protein in adolescent hepatoma. N Engl J Med. 1973 Nov 15;289(20):1053–1056. doi: 10.1056/NEJM197311152892002. [DOI] [PubMed] [Google Scholar]
  18. Waxman S., Liu C. K., Schreiber C., Helson L. The clinical and physiological implications of hepatoma B12-binding proteins. Cancer Res. 1977 Jun;37(6):1908–1914. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES